Nonclinical toxicology studies with sodium taurodeoxycholate: acute and subacute toxicity in dogs

References

• Angelico, M., et al., 1994. Effect of taurohyodeoxycholic acid, a hydrophilic bile salt, on bile salt and biliary lipid secretion in the rat. Digestive Diseases and Sciences, 39(11), 2389–2397.
   PubMed Web of Science ®Google Scholar
• Boyer, J.L., 2013. Bile formation and secretion. Comprehensive Physiology, 3(3), 1035–1078.
   PubMed Web of Science ®Google Scholar
• Chen, C.F. and Kuo, C.H., 1992. Toxic effect of bile acid ingestion in rats. Journal of the Formosan Medical Association, 91(8), 743–746.
   PubMedGoogle Scholar
• Choi, H.J., et al., 2019. Evaluation of acute and subacute toxicity of sodium taurodeoxycholate in rats. Drug and Chemical Toxicology, In press.
   Web of Science ®Google Scholar
• Copple, B.L. and Li, T., 2016. Pharmacology of bile acid receptors: evolution of bile acids from simple detergents to complex signaling molecules. Pharmacological Research, 104, 9–21.
   PubMed Web of Science ®Google Scholar
• De Bernardi di Valserra, M., et al., 1993. Chronic toxicity of taurohyodeoxycholic acid in rats. Arzneimittel-Forschung, 43(8), 880–887.
   PubMed Web of Science ®Google Scholar
• de Jong, H.K., van der Poll, T., and Wiersinga, W.J., 2010. The systemic pro-inflammatory response in sepsis. Journal of Innate Immunity, 2(5), 422–430.
   PubMed Web of Science ®Google Scholar
• Feletti, F., et al., 1993. Chronic toxicity of taurohyodeoxycholic acid in dogs. Arzneimittel-Forschung, 43(8), 888–893.
   PubMed Web of Science ®Google Scholar
• Ferrari, C., et al., 2006. Pharmacophore model for bile acids recognition by the FPR receptor. Journal of Computer-Aided Molecular Design, 20 (5), 295–303.
   PubMed Web of Science ®Google Scholar
• Greve, J.W., Gouma, D.J., and Buurman, W.A., 1989. Bile acids inhibit endotoxin-induced release of tumor necrosis factor by monocytes: an in vitro study. Hepatology, 10(4), 454–458.
   PubMed Web of Science ®Google Scholar
• Greaves, P., 1990. Histopathology of preclinical studies: interpretation and relevance in drug evaluation. New York, NY: Elsevier.
   Google Scholar
• Guo, C., et al., 2015. The G-protein-coupled bile acid receptor Gpbar1 (TGR5) inhibits gastric inflammation through antagonizing NF-κB signaling pathway. Frontiers in Pharmacology, 6, 287.
   PubMed Web of Science ®Google Scholar
• Guo, C., et al., 2016. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity, 45(4), 944.
   PubMed Web of Science ®Google Scholar
• Han, J., et al., 2004. Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 42(3), 373–380.
   PubMed Web of Science ®Google Scholar
• Han, Y.D., et al., 2011. Multienzyme-modified biosensing surface for the electrochemical analysis of aspartate transaminase and alanine transaminase in human plasma. Analytical and Bioanalytical Chemistry, 400(3), 797–805.
   PubMed Web of Science ®Google Scholar
• Jeong, E.J., et al., 2007. Hematological and blood biochemical values of laboratory beagle dogs. Laboratory Animal Research, 23, 223–229.
   Google Scholar
• Katsuma, S., Hirasawa, A., and Tsujimoto, G., 2005. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochemical and Biophysical Research Communications, 329(1), 386–390.
   PubMed Web of Science ®Google Scholar
• Kawamata, Y., et al., 2003. A G protein-coupled receptor responsive to bile acids. The Journal of Biological Chemistry, 278(11), 9435–9440.
   PubMed Web of Science ®Google Scholar
• Kim, M.S., et al., 2012. Single-dose oral toxicity of fermented scutellariae radix extract in rats and dogs. Toxicological Research, 28(4), 263–268.
   PubMedGoogle Scholar
• Kirby, J., Heaton, K.W., and Burton, J.L., 1974. Pruritic effect of bile salts. British Medical Journal, 4(5946), 693–695.
   PubMed Web of Science ®Google Scholar
• Kishimoto, S., et al., 1986. Experimental model of gastritis induced by sodium taurocholate in rats. Hiroshima Journal of Medical Sciences, 35 (2), 143–147.
   PubMedGoogle Scholar
• Lai, Y., et al., 1996. Toxicity of bile salts (sodium cholate and sodium chenodeoxycholate) in rats. Nutritional Sciences Journal, 21, 288–297.
   Google Scholar
• McMillin, M., et al., 2015. TGR5 signaling reduces neuroinflammation during hepatic encephalopathy. Journal of Neurochemistry, 135(3), 565–576.
   PubMed Web of Science ®Google Scholar
• Mukinda, J.T. and Syce, J.A., 2007. Acute and chronic toxicity of the aqueous extract of Artemisia afra in rodents. Journal of Ethnopharmacology, 112(1), 138–144.
   PubMed Web of Science ®Google Scholar
• Nam, C., et al., 2015. Single- and repeat-dose oral toxicity studies of lithospermum erythrorhizon extract in dogs. Toxicology Research, 31(1), 77–88.
   PubMedGoogle Scholar
• National Research Council. 2004. Science, medicine, and animals. Washington, DC: The National Academies Press.
   Google Scholar
• Ozdil, B., et al., 2010. Potential benefits of combined N-acetylcysteine and ciprofloxacin therapy in partial biliary obstruction. The Journal of Clinical Pharmacology, 50(12), 1414–1419.
   PubMed Web of Science ®Google Scholar
• Palmer, R.H., 1972. Bile acids, liver injury, and liver disease. Archives of Internal Medicine, 130(4), 606–617.
   PubMedGoogle Scholar
• Parasuraman, S., 2011. Toxicological screening. Journal of Pharmacology & Pharmacotherapeutics, 2(2), 74–79.
   PubMedGoogle Scholar
• Reagan-Shaw, S., Nihal, M., and Ahmad, N., 2008. Dose translation from animal to human studies revisited. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 22(3), 659–661.
   PubMed Web of Science ®Google Scholar
• Rutishauser, S.C. and Stone, S.L., 1975. Comparative effects of sodium taurodeoxycholate and sodium taurocholate on bile secretion in the rat, dog and rabbit. The Journal of Physiology, 245(3), 583–598.
   PubMed Web of Science ®Google Scholar
• Saini, S.P., et al., 2004. A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Molecular Pharmacology, 65(2), 292–300.
   PubMed Web of Science ®Google Scholar
• Sayin, S.I., et al., 2013. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metabolism, 17(2), 225–235.
   PubMed Web of Science ®Google Scholar
• Schaap, F.G., Trauner, M., and Jansen, P.L., 2014. Bile acid receptors as targets for drug development. Nature Reviews Gastroenterology & Hepatology, 11(1), 55–67.
   PubMed Web of Science ®Google Scholar
• Shin, J.W., Seol, I.C., and Son, C.G., 2010. Son interpretation of animal dose and human equivalent dose for drug development. The Journal of Korean Oriental Medicine, 31, 1–7.
   Google Scholar
• Song, C., Hiipakka, R.A., and Liao, S., 2000. Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids, 65 (8), 423–427.
   PubMed Web of Science ®Google Scholar
• Staudinger, J.L., et al., 2001. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proceedings of the National Academy of Sciences of the United States of America, 98(6), 3369–3374.
   PubMed Web of Science ®Google Scholar
• Wong, F., et al., 2005. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut, 54(5), 718–725.
   PubMed Web of Science ®Google Scholar
• Yeh, Y.H., et al., 2003. Bile acid composition in snake bile juice and toxicity of snake bile acids to rats. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology, 136(3), 277–284.
   PubMed Web of Science ®Google Scholar
• Zhou, H. and Hylemon, P.B., 2014. Bile acids are nutrient signaling hormones. Steroids, 86, 62–68.
   PubMed Web of Science ®Google Scholar